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The firefly luciferase complementation assay is widely used as a bioluminescent reporter
technology to detect protein-protein interactions in vitro, in cellulo, and in vivo. Upon the
interaction of a protein pair, complemented firefly luciferase emits light through the adenylation and oxidation of its substrate, luciferin. Although it has been suggested that kinetics of
light production in the firefly luciferase complementation assay is different from that in full
length luciferase, the mechanism behind this is still not understood. To quantitatively understand the different kinetics and how changes in affinity of a protein pair affect the light emission in the assay, a mathematical model of the in vitro firefly luciferase complementation
assay was constructed. Analysis of the model finds that the change in kinetics is caused by
rapid dissociation of the protein pair, low adenylation rate of luciferin, and increased affinity
of adenylated luciferin to the enzyme. The model suggests that the affinity of the protein pair
has an exponential relationship with the light detected in the assay. This relationship causes
the change of affinity in a protein pair to be underestimated. This study underlines the importance of understanding the molecular mechanism of the firefly luciferase complementation
assay in order to analyze protein pair affinities quantitatively.

Introduction
The firefly luciferase complementation assay (FLCA) is an assay that detects protein-protein
interactions in vitro, in cellulo, and in vivo [1, 2]. The assay detects the bioluminescence that is
emitted during the oxidation of the substrate, D-luciferin (LH2). In the assay, the N-terminal
and C-terminal domain of firefly luciferase (NFLuc and CFLuc, respectively) are genetically
fused to a protein pair of interest via a linker peptide [3]. When the protein pair interacts with
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each other, NFLuc and CFLuc reconstitute the active site of the enzyme. This results in emission of luminescence when LH2 is added in the reaction.
The FLCA can be used in many different organisms and systems. In the in vitro assays previously conducted [4], the substrates LH2 and ATP are added to a 96-well plate containing a
buffer and a protein pair fused to NFLuc and CFLuc, respectively. Luminescence is measured
in relative units (RLU) with a photomultiplier tube. In the in cellulo assay, the cells of interest
are suspended in a culture plate. LH2 is added to the culture plate so that the substrate contacts
with the enzyme via diffusion through the cell membranes. When performing FLCA in vivo,
LH2 can be injected into the circulatory system [5]. The typical FLCA luminescence kinetics
include a delayed peak followed by slow decay [4, 6]. The highest RLU detected during the
assay is generally used to evaluate the interaction of the protein pair.
The molecular mechanism of full length firefly luciferase reaction has been well established.
During the reaction, the substrate LH2 is adenylated to form the intermediate luciferyl-adenylate (LH2-AMP) (reaction 1). LH2-AMP is oxidized to from excited oxyluciferin (L-oxy?, reaction 2) which emits light when it decays to its ground state (L-oxy, reaction 3) [7]. The dark
reaction product dehydroluciferin-AMP (L-AMP, reaction 4) is formed in an alternate chemical pathway [7]. The dark reactions account for approximately 20% of all luciferase activity [7].
Both of these products, L-oxy and L-AMP, inhibit luciferase competitively against LH2[6].
Firefly luciferase is a 62 kDa peptide encoded by 550 amino acids [8]. X-ray crystallography
has revealed that the N domain is encoded in amino acids 4–436, and the C domain in amino
acids 440–544 [8]. There is a flexible hinge region between the two domains at amino acids
436–440 [8]. The flexible hinge region allows the C domain to change conformation during the
oxidation step, allowing the catalytic residue to come in contact with the substrate. Both of the
primary amino acids involved in catalysis are found on the C domain. Amino acid K529 is
responsible for adenylation of the substrate, while K443 is responsible for oxidation of the
intermediate [9, 10]. Gene mutation studies have identified amino acids 213–348 of the N
domain as binding sites for LH2 and ATP [11]. N domain residue H245 is considered the key
binding residue, as it is highly conserved throughout the acetyl-CoA synthetase, non-ribosomal
protein synthetase, and luciferase (ANL) superfamily in addition to being in the region identified as responsible for binding of substrates [11].
Mg 2þ

Luc þ LH2 þ ATP ⇄

Luc  LH2  AMP þ PPi

f1g

Luc  LH2  AMP þ O2 ! Luc  L  oxy ? þAMP þ CO2

f2g

Luc  L  oxy ? ! Luc  L  oxy þ hv

f3g

Luc  LH2  AMP þ O2 ! Luc  L  AMP þ H2 O2

f4g

In the FLCA, NFLuc consists of amino acids 1–437, and CFLuc contains 395–547 [4]. The
overlapping region common to both NFLuc and CFLuc, amino acids 395–437, includes the
ﬂexible hinge region and part of the N domain. Although the FLCA is valued for its simple protocol, it is involved in a complex system of enzymatic reactions (Fig 1). While NFLuc alone has
residual enzymatic activity (binding and catalysis of the substrates), CFLuc is key in increasing
the efﬁciency of catalysis [9, 10, 12, 13]. Hence in the FLCA, the afﬁnity of a protein pair fused
to NFLuc or CFLuc via a linker peptide inﬂuences the luminescence output by altering the
interaction between NFLuc and CFLuc.
Previously published FLCA data has interpreted protein pair interactions qualitatively (the
presence or absence of protein interactions) or quantitatively (affinities of protein interactions
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Fig 1. Overview of in vitro firefly Luciferase complementation assay (FLCA) system. (A) With
interaction of a protein pair (shown here, protein A and B), the N and C domains of luciferase (NFLuc and
CFLuc, respectively) reconstitute the active site of the enzyme. The amount of the reconstituted enzyme (NC
complex) is thought to correlate with the affinities of the protein pair. (B) Upon the addition of the substrates,
LH2 and ATP, catalysis occurs in a two step process. The enzyme first adenylate LH2 with ATP, forming the
intermediate LH2-AMP. The intermediate is then oxidized to form L-oxyluciferin (L-oxy) during the light
emission reaction. Alternatively, the intermediate is oxidized to form dehydroluciferyl-AMP (L-AMP) without
emitting light (dark reaction). Both products inhibit luciferase activity competitively. NFLuc has low luciferaseactivity on its own [12, 13].
doi:10.1371/journal.pone.0148256.g001

are compared based on the RLU) [1, 2, 14–16]. We searched for articles with the keywords
‘luciferase complementation assay’ using Google Scholar, and identified the first 46 peerreviewed articles in the result list. Among the 46 articles, we found that 50% of 46 previously
published peer-reviewed articles using the FLCA claim that the maximum RLU detected during the assay is a quantitative measurement of the affinity of the protein interactions [5, 14, 17–
60]. In such articles, FLCA data are considered quantitative because of an assumption that the
reconstituted activity of NFLuc and CFLuc is entirely and linearly dependent upon the affinity
of the protein pair of interest and the concentration of the interacting complex.
However, the relationship between changes of the affinity of the protein pair and the luminescence detected with the FLCA has not been quantitatively understood. In fact, it has been
previously suggested that the kinetics of luminescence production in the FLCA is different
from that in full length firefly luciferase [12–14]. Without a thorough understanding of the
cause for these changes in the luminescence kinetics, or a demonstration of the relationship
between protein interaction and luminescence, the FLCA cannot reasonably be considered a
quantitative measure of either protein pair affinity or the concentration of the protein pair
complex. The purpose of this study is to quantitatively understand the relationship between
changes of the affinity of a protein pair and the luminescence detected in the FLCA using a
mathematical model. The model is constructed with ordinary differential equations (ODEs)
using known enzymatic reactions and equilibrium constants for both firefly luciferase and the
protein pair. Using the model, we analyze the degree to which luminesence observed in the
FLCA is affected by the interaction of a protein pair.
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Materials and Methods
Measurement of the kinetics of in vitro FLCA
Kinetic data of luminescence production in FLCA was obtained under the same conditions as
previously published in [4]. Briefly, purified recombinant protein of p53 and mdm2 fused to
NFLuc and CFLuc (50 nM each) were suspended in a 2x enzyme solution containing 100 mM
MOPS, 10 mM MgSO4, pH 7.3 [4]. The mixture (50 μl) was dispensed to a well in a white
96-well plate (Corning-Costar, NY, USA) after incubation at 37°C for 120 s. The light intensity
was measured immediately after injection of 50 μl 2x substrate solution (40 mM ATP and 150
μM LH2 in 100 mM MOPS, 10 mM MgSO4, pH 7.3) with a periodical integration for 0.1 s
using Phelios AB-2350 luminometer (ATTO, Tokyo, Japan).

Measurement of the kinetics of in vitro full length firefly luciferase
Kinetic data of luminescence production in full length firefly luciferase was obtained under the
same conditions as that in FLCA. Briefly, firefly luciferase was purchased from Promega (Wisconsin, USA). Luciferase enzyme (150 nM or 450 nM) was suspended in 100 mM MOPS, 19
mM MgSO4, pH 7.3. One microliter of the enzyme solution and 50 μL of a 2x ATP solution (40
mM ATP in 100 mM MOPS, 10 mM MgSO4, pH 7.3) was dispensed to a well in a white
96-well plate (Corning-Costar, NY, USA). The luminescence was measured immediately after
injection of a 2x LH2 solution (150 μM LH2, 100 mM MOPS, 10 mM MgSO4, pH 7.3) with
periodical integration for 0.2 s for 120 s using Synergy 2 luminometer (Biotek, Vermont, USA).

Calculation of the degradation of NFLuc and CFLuc
The degradation of NFLuc and CFLuc were previously analyzed and published [4]. To obtain a
degradation rate for these species, the data were analyzed using Eq 1 which describes exponential degradation. The maximum RLU, representative of relative enzymatic activity, was digitized
for each incubation time using PlotDigitizer and normalized [61]. The degradation rate was calculated by curve fitting to Eq 1 using Matlab’s nlinfit function for nonlinear regression [62].
Activity ¼ eDegradationRateTime

ð1Þ

Estimation of parameters
Initial estimates for parameters were taken from the literature. Initial estimates for all kon rates
were held between the physiologically relevant range of 105−108 M−1 throughout the optimization process [63]. Parameters unavailable from the literature were estimated by curve fitting
the model to previous data. Ordinary differential equations (ODEs) were numerically solved
with MatLab’s ode23s for stiff systems [62]. The curve fitting was done using MatLab’s lsqcurvefit function.

Calculation of initial conditions
The initial concentrations of the non-interacting and interacting protein pair prior to the addition of substrates was calculated with the system of equations shown in S1 ODE. This uses the
kon and koff for the protein pair, the initial concentration of the proteins, and the degradation
rate of NFLuc and CFLuc. The kon and koff of the protein pair, here p53 and mdm2, was
obtained from the literature [64]. The incubation time was estimated for 1 s due to the delay
associated with manual portions of the procedure when no incubation time was defined by the
experimenters.
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Calculation of the IC-50
The Ki of nutlin-3 was estimated using Eq 2 [65]. To calculate the IC-50 from the model simulation of the p53 and mdm2 interaction, we first plotted the simulated RLU at 0.2 s, following
the previous experimental procedure [4]. We then fit these points to Eq 3 using nonlinear
regression. This equation is a 4 parameter logistic model, where the parameters min and max
are asymptotes which the data approaches but does not touch. The IC-50 point is a calculated
number halfway between these two asymptotes. Nonlinear regression and plotting was accomplished using a modified form of the independently designed DoseResponse package for
Matlab [66].
Ki ¼

IC50
½NFLuc
þ1
Kd

Activity ¼ max þ

min  max
½nutlin  3
1þ
IC  50

ð2Þ

ð3Þ

Simulation of full length kinetics
The mathematical model describing the FLCA was stripped down to simulate only the NC
complex (S4 ODE). In order to calculate the koffs for full length luciferase, we used the kons
obtained from the optimization of the NC complex and dissociation constants from the literature, using Eq 4 (S2 Table).
Kd ¼

koff
kon

ð4Þ

Results and discussion
Kinetics of light production in the FLCA and full length luciferase are
different
Previous independent studies suggest that the kinetics of luminescence production in full
length luciferase and those of the FLCA would be different [12–14]. We therefore conducted
experiments that directly compared the kinetics of luminescence production in the FLCA and
full length luciferase (Fig 2). In this experiment, we used 50 nM each of p53-NFLuc and
mdm2-CFLuc. The proteins p53 and mdm2 are known to interact with each other in vitro with
a dissociation constant (Kd) of 212 nM [64].
In our experimental conditions, the luminescence kinetics of 150 nM full length firefly luciferase was measured after adding 75 μM LH2 and 100 mM ATP. Full length firefly luciferase
shows a sharp peak within the first second, followed by fast signal decay (Fig 2). These kinetics
are observed regardless of the different concentrations of full length firefly luciferase used (S1
Fig) [7]. On the other hand, the luminescence kinetics of the FLCA shows a slower peak with
slower signal decay (Fig 2). Previous data shows that the luminescence kinetics of FLCA is
independent from protein concentrations used in the assays [4]. Our results, therefore, confirmed the previous suggestion that the kinetics of luminescence production in the FLCA and
full length luciferase are different. This result also suggested that the different luminescence
kinetics are due to factors other than insufficient substrates in the reaction solution.
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Fig 2. Luminescence kinetics of full length luciferase (black) and of the FLCA (red) are different.
Changes in the relative luminescence of full length luciferase and of the FLCA in vitro were monitored every
0.2 s and 0.1 s, respectively, for 120 s in a 96-well plates. Detected luminescence was normalized so that the
maximum luminescence in each assay is 1. Notice that the kinetics of 150 nM full length firefly luciferase has
a sharp peak within 1 s followed by quick decay. On the other hand, the kinetics of 50 nM NFLuc and 50 nM
CFLuc has a more delayed peak and slower decay.
doi:10.1371/journal.pone.0148256.g002

Functions of the N and C domains in firefly luciferase were incorporated
into a mathematical model
The kinetics of a firefly luciferase mutant with a C domain deletion have been studied previously [12, 13]. The kinetics of the deleted mutant is significantly different from full length luciferase (Fig 3). In our analysis of the FLCA, it was apparent that the kinetics of the FLCA are
different from both full length luciferase and the deletion mutant (Figs 2 and 3). It has been
shown that NFLuc alone can bind and adenylate LH2 and oxidize the intermediate, although
the activity is 10−5 fold of the full length [12]. Hence, we incorporated the independent function of NFLuc, CFLuc, and the NC complex in modeling the FLCA (Fig 4).
Our equations were written based on the following assumptions. NFLuc and CFLuc reconstitute the active site of firefly luciferase upon the association of the protein pair fused to NFLuc
and CFLuc, respectively [3]. ATP and LH2, the substrates of firefly luciferase, can bind to NFLuc
independently from CFLuc [11]. With both substrates bound, NFLuc catalyzes the adenylation
and oxidation reactions, but at a much lower rate than when CFLuc is present [13, 67]. The
reconstituted active site is disrupted by dissociation of the protein pair fused to NFLuc and
CFLuc. The two products, L-oxy and L-AMP, inhibit luciferase competitively upon formation [6,
7]. L-oxy is the light emitter and the primary product, while L-AMP does not produce light [7].

System of ordinary differential equations describing the FLCA
dx1
¼  c1  x1  x21 þ c2  x2  c9  x1  x6 þ c10  x16  c7  x1  x3 þ c8  x15
dt
 c26  x1  x14 þ c25  x19  c28  x1  x12 þ c27  x20  c15  x1  x9 þ c16  x18
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Fig 3. Curve fit of the in vitro luminesence kinetics of the N domain of firefly luciferase. Data originally
published in [12] was digitized using Plot Digitizer [61]. Digitized data was curve fit to estimate parameters
unavailable from previously published papers. (A) The addition of 3.7 nM LH2-AMP to 1 μM of the N domain
shows a sharp peak. This curve fit provided an estimation of the adenylation forward and reverse rates. (B)
When a substrate solution (300 μM LH2, 10 mM ATP) is added to 1 μM of the N domain, the luminescence
kinetics have a slow rise and no peak. This curve fit provided more optimized values for the available NFLuc
alone binding and catalysis rates in the FLCA.
doi:10.1371/journal.pone.0148256.g003

Fig 4. Diagram describing the complete set of reactions used to develop a mathematical model for the
in vitro FLCA. The interaction of the protein pair (orange arrows) fused to NFLuc (grey panels) and CFLuc
(not shown) forms the NC complex (white panels), which reconstitutes enzymatic activity. The reconstituted
activity produces luminescence by the adenylation and oxidation of LH2. NFLuc contains all known substrate
binding residues and can catalyze the reactions on its own [12, 13], and some luminescence can be
produced without the interaction of the protein pair. The mathematical model takes into account enzymatic
reaction of NFLuc alone and NC complex. The equations describing the reactions of NFLuc mirror that of the
NC complex. “x” refers to variable number in the model for each species, and “c” refers to the reaction rate
parameters. N: NFLuc. NC: NC complex. A: ATP. L: LH2. NC-A: NC bound to ATP. NC-L: NC bound to LH2.
NC-LA: NC bound to LH2 and ATP. NC-I: NC bound to LH2-AMP. I: Free LH2-AMP. NC-LOXY: NC bound to
L-oxy. NC-LAMP: NC bound to L-AMP. LOXY: Free L-oxy. LAMP: Free L-AMP. LIGHT: Observed
luminescence. N-A: NFLuc bound to ATP. N-L: NFLuc bound to LH2. N-LA: NFLuc to LH2 and ATP. N-I:
NFLuc bound to LH2-AMP. N-LOXY: NFLuc bound to L-oxy. N-LAMP: NFLuc bound to L-AMP.
doi:10.1371/journal.pone.0148256.g004
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dx2
¼ c1  x1  x21  c2  x2  c3  x2  x3 þ c4  x4  c5  x2  x6 þ c6  x5  c23
dt
 x2  x12 þ c24  x11  c21  x2  x14 þ c22  x10  c15  x2  x9 þ c16  x8

ð6Þ

dx3
¼  c3  x2  x3 þ c4  x4  c3  x5  x3 þ c4  x7  c7  x1  x3
dt
þ c8  x15  c7  x16  x3 þ c8  x17

ð7Þ

dx4
¼ c3  x2  x3  c4  x4  c5  x4  x6 þ c6  x7 þ c1  x15  x21  c2  x4
dt

ð8Þ

dx5
¼  c3  x5  x3 þ c4  x7 þ c5  x2  x6  c6  x5 þ c1  x16  x21  c2  x5
dt

ð9Þ

dx6
¼  c5  x2  x6 þ c6  x5  c5  x4  x6 þ c6  x7  c9  x1  x6
dt
þ c10  x16  c9  x15  x6 þ c10  x17

ð10Þ

dx7
¼ c3  x5  x3  c4  x7 þ c5  x4  x6  c6  x7
dt
þ c1  x17  x21  c2  x7  c11  x7 þ c12  x8

ð11Þ

dx8
¼ c11  x7  c12  x8 þ c1  x18  x21  c2  x8  c19  x8 þ c15  x2  x9  c16  x8
dt

ð12Þ

dx9
¼  c15  x2  x9 þ c16  x8  c17  x1  x9 þ c18  x18
dt

ð13Þ

dx10
¼ c19  x8  ð1  c29 Þ þ c1  x19  x21  c2  x10 þ c21  x2  x14  c22  x10
dt

ð14Þ

dx11
¼ c19  c29  x8 þ c1  x20  x21  c2  x11 þ c23  x2  x12  c24  x11
dt

ð15Þ

dx12
¼  c23  x2  x12 þ c24  x11  c28  x1  x12 þ c27  x20
dt

ð16Þ

dx13
¼ c19  x8  ð1  c29 Þ  x13 þ c20  x18  ð1  c29 Þ
dt

ð17Þ

dx14
¼  c21  x2  x14 þ c22  x10  c26  x1  x14 þ c25  x19
dt

ð18Þ

dx15
¼ c7  x1  x3  c8  x15  c9  x15  x6 þ c10  x17  c1  x15  x21 þ c2  x4
dt

ð19Þ

dx16
¼ c9  x1  x6  c10  x16  c7  x16  x3 þ c8  x17  c1  x16  x21 þ c2  x5
dt

ð20Þ
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dx17
¼  c13  x17 þ c14  x18 þ c9  x15  x6  c10  x17 þ c7  x16  x3
dt
 c8  x17  c1  x17  x21 þ c2  x7

ð21Þ

dx18
¼ c13  x17  c14  x18  c1  x18  x21 þ c2  x8  c20  x18 þ c17  x1  x9  c18  x18 ð22Þ
dt
dx19
¼ c20  ð1  c29 Þ  x18  c1  x19  x21 þ c2  x10 þ c26  x1  x14  c25  x19
dt

ð23Þ

dx20
¼ c20  c29  x18  c1  x20  x21 þ c2  x11 þ c28  x1  x12  c27  x20
dt

ð24Þ

dx21
¼  c1  x21  x1  c1  x21  x15  c1  x21  x16  c1  x21  x17  c1  x21  x20
dt
 c1  x21  x19 þ c2  x2 þ c2  x4 þ c2  x5 þ c2  x11 þ c2  x10 þ c2  x7
 c1  x21  x18 þ c2  x8

ð25Þ

Parameters were optimized by curve fitting to experimental data
We first obtained initial estimates for the parameters from the literature (Table 1). Then we
attempted to estimate the adenylation rate of LH2, which is unknown for NFLuc. To this end,
we selected ODEs that represent the binding and catalysis events of NFLuc without CFLuc in
the FLCA, NFLuc alone (S2 ODE). We then applied known parameters, which were experimentally obtained in two independent studies (Table 1). The first study was conducted in vitro
with a double mutant in the C domain of firefly luciferase [10]. The second study was conducted in vitro with firefly luciferase that has a nonsense mutation in the end of the N domain,
resulting the loss of the C domain [12]. To estimate the adenylation rate of LH2, we curve fit
the numerical solutions of the selected ODEs with known parameters to luminescence data
that were obtained in vitro with the nonsense mutation of firefly luciferase (Fig 3) [13].
The parameters were optimized using the system of ODEs representing all the enzymatic
reactions occurring in the FLCA. We curve fit the numerical solutions of the ODEs to in vitro
FLCA luminescence data (Fig 5). These data were obtained by conducting FLCA with NFLuc
fused to the C terminal end of p53, and CFLuc fused to the C terminal end of mdm2 [4]. We
used the dissociation constant of 212 nM for the p53-NFLuc and mdm2-CFLuc interaction that
was previously obtained for the p53 and mdm2 interaction [64]. The optimized parameters of
the model obtained through the curve fits are summarized in Table 2 and detailed in S1 Table.

Reliability of the model was validated by simulating in vitro FLCA
To validate the model and optimized parameters (S1 Table), we simulated an IC-50 curve by
modifying the mathematical model to reflect the three way interaction. The IC-50 can be
defined as the point at which the observed binding of two proteins is decreased by 50% by an
inhibitor [70]. The Ki is an objective measurement of the affinity of a protein and the inhibitor
[65]. The IC-50 and the Ki are not perfectly correlated due to several factors, including competition from the protein’s partner [65]. Using Eq 2, a correction factor which takes into account
the strength of binding between the target protein and its binding partner and the concentration of the proteins is therefore applied to the observed IC-50 [65].
Ohmuro et al. previously examined the IC-50 of nutlin-3, a specific binding inhibitor of
mdm2, using the in vitro FLCA [4]. In the experiment, they measured the RLU immediately
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Table 1. Parameters Derived from the Literature.
Parameters for full length luciferase
LH2 Afﬁnity

7.2–15 μM

[9, 12]

ATP Afﬁnity

160–230 μM

[9, 12]

LH2-AMP Afﬁnity

4.7 μM

[10]

Adenylation Rate

110−3 s−1

Estimated‡ [10]

Catalytic Activity

0.23 s−1

[10]

LH2 Afﬁnity

26–67 μM

[9, 12]

ATP Afﬁnity

560–6900 μM

[9, 12]

Parameters for NFLuc alone*

LH2-AMP Afﬁnity

0.55 μM

[10]

Adenylation Rate

110−5 s−1

Estimated‡ [10]

Catalytic Activity

3.1110−5 s−1

[10]

L-AMP Afﬁnity

3.8 nM

[6, 7, 68]

L-Oxy Afﬁnity

500 nM

[6, 7]

Dark Reaction Frequency

> 0.2

[7, 9]

Degradation of NFLuc and CFLuc

1.3610−3 s−1

Calculated† [4]

Parameters shared between the NC complex and NFLuc alone

Parameters describing the protein pair
p53 and mdm2 Afﬁnity

212 nM

[64]

kon of p53 and mdm2

9.210−3 nM−1 s−1

[64]

koff of p53:mdm2

2 s−1

[64]

Nutlin-3 and mdm2 Afﬁnity

216–250 nM

Calculated†

FRB and Rapamycin Afﬁnity

26 μM

[69]

FKBP and Rapamycin Afﬁnity

200 pM

[69]

FRB and FKBP:Rapamycin Afﬁnity

12 nM

[69]

Initial estimates for parameter values were taken from the literature where available. Some values were
calculated from experimental results (†) or estimated (‡) from relative rate comparisons. Values for mutant
luciferases with a C domain deletion [12] or without the catalytic residues on the C domain [10] are reported
here (*).
doi:10.1371/journal.pone.0148256.t001

(0.2 sec) after adding the substrates to 100 nM each of p53-NFLuc and mdm2-CFLuc. Nutlin-3
inhibits the p53-mdm2 interaction by binding to mdm2. We estimated the Ki of nutlin-3 to be
235 nM using previously obtained data and Eq 2 [4]. We added ODEs describing the interaction of an inhibitor to a mdm2 fused to CFLuc (S3 ODE) to Eqs 5 through 25. Using nonlinear
regression to Eq 3, we calculated the IC-50 of our simulation to be 440 nM, and the IC-50 of
the previous experiment to be 390 nM (Fig 6) [70]. We assume one of the causes for the difference between the experimental data and model simulation is due to disturbances in the mixing
of the substrate and enzyme solutions after injection, which would occur within the first second
of the reaction. Nonetheless, the results suggest that the model and parameters of the FLCA
identified in this study reasonably simulate the IC-50.
As an additional validation step, we simulated the FLCA at different concentrations of
NFLuc-p53 and CFLuc-mdm2 (S4 Fig). These results also suggest that the model and parameters accurately reflect the FLCA conditions, with the exception of early time points (within the
first second). We assume this discrepancy is also due to the disturbance of the solution after
injection of the substrate solution in the experiment. As a further validation step, we simulated
the in vitro FLCA for a second protein pair, NFLuc-FRB and CFLuc-FKBP in the presence of
equimolar rapamycin (S5 Fig). Rapamycin preferentially binds FKBP, allowing it to interact
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Fig 5. Model simulation (red) of the luminescence kinetics of p53-NFLuc and mdm2-CFLuc using in
vitro FLCA compared to the data (black) after optimization. The values for the parameters in the
mathematical model were estimated in three steps. First, parameter values were taken from the previously
published literature when able, or calculated from previous data (Table 1). Second, additional parameter
values were estimated by curve fitting the model to the luminescence kinetics of NFLuc alone [12] (Fig 3).
Finally, the binding and catalysis rates of the NC complex were optimized by curve fitting (red) to the
luminescence kinetics of 50 nM each of p53-NFLuc and mdm2-CFLuc obtained in this study (black).
doi:10.1371/journal.pone.0148256.g005

with FRB [69]. This three-way molecular interaction has a 20 times higher affinity than
p53-mdm2 (Table 1). Simulating the interaction between FKBP and FRB in the presence of
rapamycin using the in vitro FLCA with the optimized parameters reasonably agrees with the
previously obtained in vitro FLCA data [4]. This result again suggests that the model and
parameters accurately model the in vitro FLCA. For both NFLuc-p53:CFLuc-mdm2 and
NFLuc-FRB:CFLuc-FKBP we found a linear relationship between the maximum RLU detected
and the concentration of the protein pair used in the experiments (Fig 7). The model predicts
that the relationship between the maximum RLU and the concentration of the protein pair will
be linear (Fig 7) but the concentration affects the kinetics of light emission. Namely, the
Table 2. Comparison of Experimental and Estimated Values.
Parameter

Full length (experimental)†

NC complex (estimated)‡

NFLuc alone (estimated)‡

N domain (experimental)†

LH2 Afﬁnity

7.2–15 μM [9, 12]

16 μM

27.50 μM

26–67 μM [9, 12]

ATP Afﬁnity

160–230 μM [9, 12]

160 μM

683 μM

560–6900 μM [9, 12]

LH2-AMP Afﬁnity

4.70 μM [10]

45 nM

45 nM

550 nM [10]

L-oxy Afﬁnity

500 nM [6, 7, 68]

70 nM

70 nM

–

L-AMP Afﬁnity

3.80 nM [6, 7]

45 pM

45 pM

–

Adenylation Rate

–

500 s−1

0.004 s−1

–

Oxidation Rate

0.23 s−1[10]

0.22 s−1

4.0010−7 s−1

3.1110−5 s−1[10]

Dark Reaction Frequency

0.2 [7, 10]

0.29

0.29

> 0.2 [10]

†

: Values obtained from the literature.
: Estimated values were obtained from the curve ﬁt.

‡

–: data unavailable. Values for mutant luciferases without the catalytic residues on the C domain [10] or with a C domain deletion [12] are also reported
here.
doi:10.1371/journal.pone.0148256.t002
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Fig 6. Nutlin-3 IC-50 curve (red), simulated using the in vitro FLCA model, agrees with the
experimental data (black). Experimental RLU values of the FLCA with 100 nM each of p53-NFLuc and
mdm2-CFLuc at 0.2 s (black) are compared with simulated RLU values (red) across a range of nutlin-3
concentrations [4]. The calculated IC-50 of the experimental data is 390 nM, while the simulation IC-50 is 440
nM.
doi:10.1371/journal.pone.0148256.g006

Fig 7. The model predicts a linear relationship between maximum RLU and concentration of the
protein pair. Maximum RLU values obtained experimentally (black) are compared with simulated RLU
values for (A) NFLuc-FRB, CFLuc-FKBP, and equimolar rapamycin (red) and (B) NFLuc-p53 and CFLucmdm2 (blue). The linear trendlines were calculated using nonlinear regression. The experimental data was
obtained from [4].
doi:10.1371/journal.pone.0148256.g007
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concentration of a protein pair affects the concentration of the inhibitory products, which
affect the rate of light emission after the maximum RLU is reached (S6 Fig).

The model and parameters obtained by the curve fit brought us a
quantitative understanding of the luminescence production in in vitro
FLCA
9 The model and parameters obtained in this study expanded our understanding of luminesence production in the FLCA with two important findings. First, previous experimental data
showed that a mutant of the C domain residues K443 caused some changes in enzymatic activity. The mutation reduced the LH2-AMP oxidation rate by about 7000 times, from 0.23 s−1 in
full length luciferase to 3.1110−5 s−1 in the mutant (Table 2) [10]. On the other hand, the binding affinity for LH2-AMP increased by 8 times in the mutant, from 4.7 μM in full length luciferase to 550 nM in the mutant (Table 2) [10]. These data indicate that K443 in the C-domain of
firefly luciferase increased the oxidation rate of LH2-AMP while reducing the binding affinity
of the N-domain for LH2-AMP [10].
The optimized parameters in the FLCA show a similar trend. The oxidation rate of LH2AMP by NFLuc alone is 4.0010−7 s−1 (Table 2). This is about 78 times slower than that of the
mutant. On the other hand, the optimized parameters of the binding of LH2-AMP by NFLuc
alone is 45 nM (Table 2). This is a 12 times higher affinity than that of the mutant. These
parameters suggest that removing the C domain from the firefly luciferase peptide exaggerates
the effects of the mutant.
Second, when the active site is reconstituted within the NC complex through the interaction
of the proteins fused to NFLuc and CFLuc, the affinity of LH2 increases from 27.5 μM in
NFLuc alone to 16 μM in the NC complex. This is comparable to the full length affinity to LH2,
which has been measured between 7.2–15 μM [9, 12]. The affinity of ATP also increases from
683 μM in NFLuc alone to 160 μM in the NC complex. This is also within the range of previously obtained full length affinity to ATP (160–230 μM) [9, 12]. The oxidation rate of the NC
complex was estimated to 0.22 s−1, which is very close to experimental values for full length
luciferase (0.23 s−1) [10]. On the other hand, the adenylation rate of LH2 by the NC complex
was estimated to be 500 s−1, which is about 105 times higher than the value we obtained for
NFLuc alone (0.004 s−1). Overall, the set of optimized parameters suggest that the NC complex
reconstitutes the oxidation activity of full length firefly luciferase, while the affinities of the NC
complex to LH2-AMP, L-oxy, and L-AMP are higher than the affinities experimentally
obtained for full length firefly luciferase (Table 2).

The mathematical model explains that the alternation of the kinetics in
FLCA is due to rapid dissociation of the protein pair, lower adenylation
rate, and higher affinity to LH2-AMP
Although NFLuc alone has residual enzymatic activity, the oxidation activity that generates
light is about 10−6 of the NC complex (Table 2). This suggests that the light detected in the
FLCA is mainly due to the activity of the NC complex. The model estimates the oxidative rate
of LH2-AMP in the NC complex is 0.22 s−1 while the dissociation of p53 and mdm2, fused to
NFLuc and CFLuc respectively, is 2.0 s−1[64]. This suggests the active site formed in the NC
complex dissociates about 10 times faster than the rate of LH2-AMP oxidization. The model
suggests that this causes the delayed peak in the FLCA (Fig 8(A)). For example, a hypothetical
protein pair with a Kd of 10 pM dissociates at a rate of approximately 110−4 s−1[63]. The
model suggests that such a protein pair reaches its peak RLU around at 2.5 sec, while a protein
pair with Kd of 212 nM (p53-mdm2) reaches the peak around at 5.0 sec.
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Fig 8. The model suggests that the delayed peak of the FLCAis due to dissociation of the protein pair,
while the slow decay isdue to the lower adenylation rate and higher affinity toward LH2-AMP. (A)
Luminesence kinetics of FLCAs and full length luciferase was predicted by the model. The protein pair with Kd
= 10 pM (blue) shows a faster peak and decay, compared with the protein pair with Kd = 212 nM (red). (B)
Luminesence kinetics of FLCA, hypothetical split luciferase, and full length was predicted by the model. FLCA
with the protein pair Kd of 212 nM (red) compared with a hypothetical split luciferase (blue) with the same Kd.
The hypothetical split luciferase has the same adenylation rate and affinity to LH2-AMP as full length
luciferase. Enzyme concentration used for these simulations was 50 nM.
doi:10.1371/journal.pone.0148256.g008

The model further suggests that two factors cause the slow decay of the FLCA: the lower
adenylation rate (estimated to be 500 s−1 for the NC complex, and 5000 s−1 for full length luciferase), and a higher affinity to LH2-AMP. To demonstrate this, we simulated the kinetics of full
length firefly luciferase, the FLCA, and a hypothetical split luciferase that has full length values
for the adenylation rate and the affinity and LH2-AMP, and FLCA values for all other parameters (Fig 8(B)). The hypothetical split luciferase shows similar kinetics to the full length,
although the peak is still delayed.

The mathematical model reveals maximum RLU detected in the FLCA
would underestimate changes in Kd of an interacting protein pair
Although the observed RLU in the FLCA is expected to correlate with the degree of interaction
of the protein pair, it is unknown how direct this correlation is. To address the question, the
relationship between changes in affinity of a protein pair and RLU was analyzed using the
mathematical model and parameters obtained in this study.
The model suggests that the relationship between the Kd (the affinity of a protein pair) and
the RLU is exponentially rather than linearly correlated. To demonstrate the relationship, we
evaluated protein pair affinities over 24 different values, from 2.5 nM to 3 μM (Fig 9(A)). This
simulation demonstrates that the comparison of the RLU obtained using FLCA can be misleading about changes of the affinity of the protein pair. For example, when comparing the maximum RLU at 10 nM and 50 nM affinity, there is a 5 times decrease in the protein pair affinity,
but only a 1.45 times decrease in the maximum RLU (Fig 9(B)). This suggests that the FLCA
would underestimate changes in the Kd of protein pairs.
This finding raises a question about the most valid interpretation of the FLCA data. Some
previously published papers claim that the Kd of the protein pair has a direct, linear relationship with the RLU detected with in cellulo FLCA [1, 14]. It is conceivable that more variables
and parameters are needed to construct a mathematical model of in cellulo FLCA. The variables
specific for in cellulo include protein synthesis and degradation, diffusion rates of the substrates
across cell membranes, and the conversion of L-AMP to dehydroluciferyl-Coenzyme A by
Coenzyme A [71]. However, one can expect the same exponential relationship between the
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Fig 9. Directly comparing the RLU obtained by the FLCA may cause misunderstandings about their
affinities. (A) Predicted relationship between changes of Kd (from 2.5 nM to 3 μM) for a protein pair and the
RLUs detected in the FLCA. The model predicts an exponential relationship between changes of Kd and
maximum RLU. (B) Predicted relationship between changes of Kd (from 10 nM to 50 nM) for a protein pair and
the RLUs detected in the FLCA. Notice the RLU detected at 10 nM (orange grid) is only 1.45 times higher that
that at 50 nM (grey grid). Enzyme concentration used for these simulations was 50 nM.
doi:10.1371/journal.pone.0148256.g009

RLU and the Kd in cellulo. We, therefore, suggest the FLCA data be interpreted as a qualitative
measure of protein pair affinity until a detailed analysis or control experiment can be conducted for the in cellulo FLCA.

Conclusion
In this study, we found that the change in luminescence kinetics between the FLCA and full
length luciferase is due primarily to the rapid dissociation of the protein pair fused to NFLuc
and CFLuc, a lower adenylation rate, and an increased affinity of the NC complex to LH2AMP. Branchini et al. first demonstrated the effect of the removal of the catalytic residues of
the C terminal domain on firefly luciferase by measuring the luminescence production in a
recombinant protein [10]. The model constructed in this study demonstrates that the relationship between luminescence and the affinity of the protein pair fused to NFLuc and CFLuc is
exponential rather than linear. The model explains that, due to the non-linear relationship
between the RLU and Kd of a protein pair, a single luminesence value cannot be a direct quantitative measurement of affinity or protein pair complex.
One of the most challenging aspects in the FLCA when comparing the affinities of different
protein pairs is to understand how the active site in a NC complex is reconstituted. It is known
that when NFLuc and CFLuc are fused to different locations of a protein pair (.i.e., amino- or
carboxyl- terminal end of proteins of interest via a linker peptide), the RLU observed in the
FLCA assay varies greatly [4]. This suggests that the geometry of NFLuc and CFLuc in the
interacting protein pair influences how the active site is reconstituted. In other words, NFLuc
and CFLuc may not be able to reconstitute the fully active NC complex, depending on their
geometry. This phenomenon particularly demonstrates that direct comparison of RLUs
between different protein pairs, especially when the 3D structures of the proteins are largely
different, must be considered qualitative. Quantitative analysis with the FLCA is possible, as
demonstrated previously by Ohmuro et al. with their IC-50 analysis and our mathematical
model in this study [4]. We suggest that the titration of known concentrations of CFLuc to a
small concentration of NFLuc, such as for a traditional protein interaction assay, is required to
obtain quantitative results for in vitro FLCA [72].
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Supporting Information
S1 Fig. Kinetics of full length firefly luciferase is independent of concentration. (A) Kinetics
at 150 nM of firefly luciferase. (B) Kinetics at 450 nM of firefly luciferase.
(TIF)
S2 Fig. Determination of the degradation rate of NFLuc and CFLuc at 37°C. Previously the
heat stability of NFLuc and CFLuc was analyzed by measuring the activity after incubation
times ranging from 0 to 60 minutes at 37°C [4]. To calculate the degradation rate, the RLU values were digitized using PlotDigitizer and the maximum RLU values were extracted [61]. The
RLU value for no incubation time was considered 100% activity. This was curve fit to an equation describing degradation (Eq 1). The degradation rate was found to be 0.00136 s−1.
(TIF)
S3 Fig. Determination of the initial concentration of NC complex. Initial concentration of
free NFLuc-p53, free CFLuc-mdm2, and NC complex was modeled using the affinity for p53
and mdm2 from the literature [64]. (A) For luminescence kinetic data with incubation at 37°C
(shown in Figs 2 and 5), the degradation rate was included in the calculation of initial conditions. (B) For luminescence kinetics data without any incubation (see S4 Fig), probes were not
incubated, but an average experimental delay of approximately 1 s is assumed.
(TIF)
S4 Fig. The mathematical model (red) reasonably matches experimental data (black) at
varying concentrations of NFLuc-p53 and CFLuc-mdm2. (A) 50 nM of NFLuc-p53 and
CFLuc-mdm2 each. (B) 150 nM of NFLuc-p53 and CFLuc-mdm2 each. (C) 450 nM of NFLucp53 and CFLuc-mdm2 each. Each simulation was separately optimized with respect to the
effects of the detection lens (photomultiplier tube). Data obtained from [4].
(TIF)
S5 Fig. The mathematical model (red) reasonably matches experimental data (black) at
varying concentrations of NFLuc-FRB and CFLuc-FKBP:rapamycin. (A) 28 nM of NFLucFRB and CFLuc-FKBP:rapamycin each. (B) 83 nM of NFLuc-FRB and CFLuc-FKBP:rapamycin each. (C) 250 nM of NFLuc-FRB and CFLuc-FKBP:rapamycin each. (D) 750 nM of
NFLuc-FRB and CFLuc-FKBP:rapamycin each. Each simulation was separately optimized with
respect to the effects of the detection lens (photomultiplier tube). Data obtained from [4].
(TIF)
S6 Fig. The mathematical model predicts the concentration of the protein pair affects the
kinetics. The concentration of a protein pair with a Kd of 100 nM was varied from 5 nM to 15
μM. The concentration of the protein pair affects the amount of inhibitory products in solution
after the light emission peak is reached. When the concentration is higher than the Kd of the
protein pair, a clear peak (maximum RLU) will be most easily detectable in the kinetics. Green
is the 100 nM concentration simulation.
(TIF)
S1 Table. Parameter values after optimization by curve fitting mathematical model to kinetic
data. Protein pair used in obtaining the experimental data for the curve fit was p53 and mdm2.
Parameter estimations were obtained to 15 decimal points and rounded to the nearest hundreth.
(PDF)
S2 Table. Parameter values obtained from the literature. Dissociation rates (koff) calculated
by holding kon values at those found after optimization for the FLCA model.
(PDF)

PLOS ONE | DOI:10.1371/journal.pone.0148256 February 17, 2016

16 / 21

Mathematical Model of Luciferase Complementation

S1 ODE. System of equations describing the interaction and degradation of two proteins
(x1 and x2) and the interacting pair (x3). Used to calculate the initial concentrations prior to
substrate addition.
(PDF)
S2 ODE. System of ODEs describing the binding and catalysis of NFLuc only. These equations were obtained using knowledge of the enzymatic activity of NFLuc, as shown by the literature. For the purposes of publication, the numbering system was conserved between the full
in vitro FLCA ODEs by removing the portions involving interaction with CFLuc.
(PDF)
S3 ODE. System of equations describing the binding of an inhibitor (here, nutlin-3) to a
protein attached to CFLuc (mdm2). These equations were added to the in vitro FLCA ODEs
to model the IC-50 data obtained when adding nutlin-3 to NFLuc-p53 and CFLuc-mdm2.
(PDF)
S4 ODE. Here the in vitro FLCA ODEs were stripped down to be able to represent fulllength luciferase. Accordingly, only the interaction and catalysis of the NC complex is modeled here, with all references to free NFLuc or CFLuc removed.
(PDF)
S1 Code. Matlab code used to generate long and short term simulations of NFLuc-p53 and
CFLuc-mdm2, and compare it to the data.
(PDF)
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